These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 623110)

  • 21. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy.
    Paul SH
    Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270
    [No Abstract]   [Full Text] [Related]  

  • 22. Involvement of a state society of hospital pharmacists in third-party reimbursement for nondistributive services.
    Breland BD; Hayman JN
    Am J Hosp Pharm; 1982 Nov; 39(11):1937-9. PubMed ID: 7148865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economics of institutional pharmacy services under national health insurance in Australia.
    Brooks GE; Knapp DA
    Am J Hosp Pharm; 1975 Oct; 32(10):1018-22. PubMed ID: 1190213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing reimbursable clinical pharmacy programs: a goal-oriented approach.
    Pathak DS; Nold EG
    Am J Hosp Pharm; 1979 Nov; 36(11):1548-52. PubMed ID: 517545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appeals Court rejects "apples/oranges" comparison in pharmacy cost case.
    Klein RA
    Health Law Vigil; 1987 Oct; 10(22):1-2. PubMed ID: 10301956
    [No Abstract]   [Full Text] [Related]  

  • 26. Reimbursement dilemma regarding home health-care products and services.
    Curtiss FR
    Am J Hosp Pharm; 1984 Aug; 41(8):1548-57. PubMed ID: 6433706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Payment for nondistributive hospital pharmacy services--a regional survey.
    Strandberg LR; Stennett DJ; Simonson W
    Drug Intell Clin Pharm; 1978 Jul; 12(7):410-2. PubMed ID: 10308024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating clinical and distributive pharmaceutical services: implications for clinical pharmacy education.
    Lipman AG
    Am J Pharm Educ; 1986; 50(1):63-6. PubMed ID: 10281558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abolition of Pharmaceutical Reimbursement Advisory Committee: final regulation.
    Fed Regist; 1978 Aug; 43(154):35310-1. PubMed ID: 10297140
    [No Abstract]   [Full Text] [Related]  

  • 30. The Medicare Catastrophic Coverage Act of 1988 effects hospital pharmacies.
    Wilson CN
    Hosp Pharm; 1988 Nov; 23(11):1029-34. PubMed ID: 10302982
    [No Abstract]   [Full Text] [Related]  

  • 31. Time to reassess approaches to financing clinical pharmacy services.
    Curtiss FR
    Am J Hosp Pharm; 1983 Jul; 40(7):1146. PubMed ID: 6881147
    [No Abstract]   [Full Text] [Related]  

  • 32. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
    Carroll NV
    Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

  • 35. The hospital-based preferred provider organization and its potential impact on hospital pharmacy.
    Larson LN; Messier DR
    Hosp Pharm; 1986 Mar; 21(3):245-6. PubMed ID: 10275585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health Services Administration--Maternal and child health/crippled children's service program; policy statement on third-party reimbursement for services to mothers and children. General notice.
    Fed Regist; 1980 Jul; 45(130):45337. PubMed ID: 10317017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1976 third-party reimbursement experience: an interstate comparison by insurance carrier.
    Dörken H; Webb JT
    Am Psychol; 1980 Apr; 35(4):355-63. PubMed ID: 7386967
    [No Abstract]   [Full Text] [Related]  

  • 38. Reimbursement for clinical services.
    Patel N; Murdico AT
    Am J Health Syst Pharm; 2007 May; 64(9):926. PubMed ID: 17468146
    [No Abstract]   [Full Text] [Related]  

  • 39. Reimbursement for clinical pharmaceutical services in university hospitals.
    Sylvester KL
    Am J Hosp Pharm; 1982 Apr; 39(4):642-3. PubMed ID: 7081242
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacoeconomic considerations in rural hospitals.
    Lenhert P
    Cost Qual Q J; 1998 Jun; 4(2):37-42. PubMed ID: 10182598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.